Invention Grant
US08247564B2 Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity
失效
具有BETA2肾上腺素能受体激动剂和毒蕈碱受体拮抗剂活性的化合物
- Patent Title: Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity
- Patent Title (中): 具有BETA2肾上腺素能受体激动剂和毒蕈碱受体拮抗剂活性的化合物
-
Application No.: US12903365Application Date: 2010-10-13
-
Publication No.: US08247564B2Publication Date: 2012-08-21
- Inventor: Mathai Mammen , Sarah Dunham
- Applicant: Mathai Mammen , Sarah Dunham
- Applicant Address: US CA South San Francisco
- Assignee: Theravance, Inc.
- Current Assignee: Theravance, Inc.
- Current Assignee Address: US CA South San Francisco
- Agent Jeffrey A. Hagenah
- Main IPC: C07D409/00
- IPC: C07D409/00
Abstract:
The invention is directed to compounds of formula I: wherein R1, R2, R3, R4, R5, R6, R7a, R7b, W, G1, G2, a, b, c, d and m are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds.
Public/Granted literature
- US20110034694A1 COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY Public/Granted day:2011-02-10
Information query
